Bollard Group’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History
Bought
Maintained
Sold
Other funds holding CANF
TAM
MC
VKH
IA
MFS
Bollard Group's CANF Position: Q4 2015 in Review
Bollard Group sold out of Can-Fite BioPharma American Depositary Shares (CANF) in Q4 2015, closing a stake of 3 shares — an estimated $32K sold.
Bollard Group first reported a position in CANF in Q3 2015 and held it in 1 quarter. The position peaked at $32K in Q3 2015. 8 funds tracked by Wall St. Rank hold CANF as of Q4 2015.
- Bollard Group reported no remaining Can-Fite BioPharma American Depositary Shares position as of Q4 2015 after selling out during the quarter.
- Bollard Group sold 3 Can-Fite BioPharma American Depositary Shares shares in Q4 2015, an estimated $32K.
- Bollard Group first reported a position in Can-Fite BioPharma American Depositary Shares in Q3 2015 and held it in 1 quarter.
- Bollard Group's Can-Fite BioPharma American Depositary Shares position peaked at $32K in Q3 2015.
- 8 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q4 2015.
Based on Bollard Group's 13F filing for Q4 2015, filed 4 Feb 2016.